Literature DB >> 24283814

A recurrent mutation in DEPDC5 predisposes to focal epilepsies in the French-Canadian population.

C Martin1, C Meloche, M-F Rioux, D K Nguyen, L Carmant, E Andermann, M Gravel, P Cossette.   

Abstract

Familial focal epilepsy with variable foci (FFEVF) is a heterogeneous epilepsy syndrome originally described in the French-Canadian (FC) population. Mutations in DEPDC5 have recently been identified in multiple cases of FFEVF as well as in a wide spectrum of other familial focal epilepsies. In this study, we aimed to determine the frequency of mutation of this gene in our large cohort of FC individuals with FFEVF, as well as familial and sporadic cases with focal epilepsy. We report a recurrent p.R843X protein-truncating mutation segregating in one large FFEVF and two small focal epilepsy FC families. Fine genotyping suggests an ancestral allele. A new p.T864M variant, predicted to be disease-causing, was also identified in a small FC family. Overall, we identified DEPDC5 mutations in 5% of our familial and sporadic focal epilepsy cases (4/79). Our results support the view that mutations in the DEPDC5 gene are an important cause of autosomal dominant focal epilepsies in the FC population, including a founder mutation that is specific to this population. These findings may facilitate molecular diagnosis in clinical practice.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  epilepsy; familial focal epilepsy with variable foci; founder effect; mutation

Mesh:

Substances:

Year:  2013        PMID: 24283814     DOI: 10.1111/cge.12311

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  10 in total

1.  [New aspects in the field of epilepsy].

Authors:  F Rosenow; K M Klein; A Strzelczyk; H M Hamer; K Menzler; S Bauer; S Knake
Journal:  Nervenarzt       Date:  2014-08       Impact factor: 1.214

Review 2.  Genetic forms of epilepsies and other paroxysmal disorders.

Authors:  Heather E Olson; Annapurna Poduri; Phillip L Pearl
Journal:  Semin Neurol       Date:  2014-09-05       Impact factor: 3.420

3.  Tryptophan-Dependent Control of Colony Formation After DNA Damage via Sea3-Regulated TORC1 Signaling in Saccharomyces cerevisiae.

Authors:  Erica J Polleys; Alison A Bertuch
Journal:  G3 (Bethesda)       Date:  2015-05-04       Impact factor: 3.154

4.  Familial cortical dysplasia type IIA caused by a germline mutation in DEPDC5.

Authors:  Thomas Scerri; Jessica R Riseley; Greta Gillies; Kate Pope; Rosemary Burgess; Simone A Mandelstam; Leanne Dibbens; Chung W Chow; Wirginia Maixner; Anthony Simon Harvey; Graeme D Jackson; David J Amor; Martin B Delatycki; Peter B Crino; Samuel F Berkovic; Ingrid E Scheffer; Melanie Bahlo; Paul J Lockhart; Richard J Leventer
Journal:  Ann Clin Transl Neurol       Date:  2015-03-12       Impact factor: 4.511

5.  ExACtly zero or once: A clinically helpful guide to assessing genetic variants in mild epilepsies.

Authors:  Caitlin A Bennett; Slavé Petrovski; Karen L Oliver; Samuel F Berkovic
Journal:  Neurol Genet       Date:  2017-07-06

Review 6.  Pharmacogenomics in epilepsy.

Authors:  Simona Balestrini; Sanjay M Sisodiya
Journal:  Neurosci Lett       Date:  2017-01-10       Impact factor: 3.046

Review 7.  Sleep Related Epilepsy and Pharmacotherapy: An Insight.

Authors:  Jaya Kumar; Amro Solaiman; Pasuk Mahakkanukrauh; Rashidi Mohamed; Srijit Das
Journal:  Front Pharmacol       Date:  2018-09-27       Impact factor: 5.810

8.  What is the impact of a novel DEPDC5 variant on an infant with focal epilepsy: a case report.

Authors:  Chunyu Gu; Xiaowei Lu; Jinhui Ma; Linjie Pu; Xiufang Zhi; Jianbo Shu; Dong Li; Chunquan Cai
Journal:  BMC Pediatr       Date:  2022-07-30       Impact factor: 2.567

Review 9.  Conserved regulators of Rag GTPases orchestrate amino acid-dependent TORC1 signaling.

Authors:  Katie Powis; Claudio De Virgilio
Journal:  Cell Discov       Date:  2016-03-08       Impact factor: 10.849

10.  Epileptic spasms are a feature of DEPDC5 mTORopathy.

Authors:  Gemma L Carvill; Douglas E Crompton; Brigid M Regan; Jacinta M McMahon; Julia Saykally; Matthew Zemel; Amy L Schneider; Leanne Dibbens; Katherine B Howell; Simone Mandelstam; Richard J Leventer; A Simon Harvey; Saul A Mullen; Samuel F Berkovic; Joseph Sullivan; Ingrid E Scheffer; Heather C Mefford
Journal:  Neurol Genet       Date:  2015-07-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.